European Commission Approves mAbxience's Bevacizumab For The T...
- Written by LATEST ASIANET NEWS RELEASES
- Published in Asia Net
MADRID, March 31, 2021 /PRNewswire-AsiaNet/ -- - mAbxience, a global fully-fledged biotech company, with over a decade of experience in the development, manufacture and commercialization of biopharmaceuticals, is expanding patient access to biological treatments throughout Europe.The Europ...
Authors: LATEST ASIANET NEWS RELEASES